State accedendo al sito dal Paese Stati Uniti.
Per il vostro Paese (Stati Uniti) è disponibile anche una versione dedicata del sito.

Passare a Stati Uniti
 Prodotti di consumo

Maschere per NIV Pulmodyne: progettate per adattarsi

Adulto con maschera per NIV Pulmodyne Adulto con maschera per NIV Pulmodyne

Maschere per NIV Pulmodyne: il massimo comfort per i pazienti

Le maschere BiTrac Pulmodyne hanno un profilo morbido e modellato sulla conformazione anatomica che assicura la tenuta sul viso, oltre a un cuscinetto per la fronte che le rende comode e facili da indossare (Sadeghi S, Fakharian A, Nasri P, Kiani A. Comparison of Comfort and Effectiveness of Total Face Mask and Oronasal Mask in Noninvasive Positive Pressure Ventilation in Patients with Acute Respiratory Failure: A Clinical Trial. Can Respir J. 2017;2017:2048032. doi:10.1155/2017/20480321). Le maschere monouso sono compatibili per la ventilazione di pazienti che respirano spontaneamente e necessitano di ventilazione non invasiva (NIV).

Il nostro portfolio di maschere per NIV

Proponiamo maschere per pazienti pediatrici e adulti. È possibile scegliere tra configurazioni nasali, oronasali e MaxShield disponibili in diverse misure in base all'opzione che meglio si adatta a ciascun paziente.

Comparison of Comfort and Effectiveness of Total Face Mask and Oronasal Mask in Noninvasive Positive Pressure Ventilation in Patients with Acute Respiratory Failure: A Clinical Trial.

Sadeghi S, Fakharian A, Nasri P, Kiani A. Comparison of Comfort and Effectiveness of Total Face Mask and Oronasal Mask in Noninvasive Positive Pressure Ventilation in Patients with Acute Respiratory Failure: A Clinical Trial. Can Respir J. 2017;2017:2048032. doi:10.1155/2017/2048032

Background. There is a growing controversy about the use of oronasal masks (ONM) or total facemask (TFM) in noninvasive positive pressure ventilation (NPPV), so we designed a trial to compare the uses of these two masks in terms of effectiveness and comfort. Methods. Between February and November 2014, a total of 48 patients with respiratory failure were studied. Patients were randomized to receive NPPV via ONM or TFM. Data were recorded at 60 minutes and six and 24 hours after intervention. Patient comfort was assessed using a questionnaire. Data were analyzed using t-test and chi-square test. Repeated measures ANOVA and Mann-Whitney U test were used to compare clinical and laboratory data. Results. There were no differences in venous blood gas (VBG) values between the two groups (P > 0.05). However, at six hours, TFM was much more effective in reducing the partial pressure of carbon dioxide (PCO2) (P = 0.04). Patient comfort and acceptance were statistically similar in both groups (P > 0.05). Total time of NPPV was also similar in the two groups (P > 0.05). Conclusions. TFM was superior to ONM in acute phase of respiratory failure but not once the patients were out of acute phase.